Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
advanced technological integrations. The selected PhD candidate will have the opportunity to collaborate with prestigious institutions, including the Personal Robotics Lab at Imperial College London and the
-
| Administration and support services | Imperial College London For technical issues when applying online please [email protected] Apply online via the above ‘Apply’ button. Closing date: 6 June 2024
-
publications in the field of operations research and business analytics Contribute to projects with academic and industrial partners, e.g. KASTEL, Imperial College London, hospitals in Germany etc. Assist in
-
-motivated person who meets the academic requirements for enrolment for the PhD degree at Imperial College London. You should hold or expect to obtain a 1st class honours or a high 2:1 degree at Master’s level
-
, established jointly with Imperial College London. NTU is also home to world-class autonomous institutes – the National Institute of Education, S Rajaratnam School of International Studies, Earth Observatory
-
neurodegenerative diseases. An independent organisation, its founding partners are the Medical Research Council (MRC), Cancer Research UK, Wellcome, UCL (University College London), Imperial College London and King’s
-
consortium of Arizona State University, University of Adelaide, University of Toronto, and within the UK, Universities Cranfield, Birmingham, Cambridge, Imperial College London, and Newcastle. The HyPT will
-
will be discussed at interview. More information is available on the following web page: Work Location Framework | Administration and support services | Imperial College London . To be considered
-
, UCL (University College London), Imperial College London and King’s College London. The Crick was formed in 2015, and in 2016 it moved into a new state-of-the-art building in central London which brings
-
Imperial College London (ICL) and Royal Marsden Hospital (RMH) / Institute of Cancer Research (ICR). Our aim is to make minimally invasive tumour ablation safer and more effective by protecting tissues from